An overview of interstitial brachytherapy and hyperthermia.
Interstitial thermoradiotherapy, an experimental cancer treatment that combines interstitial radiation implants (brachytherapy) and interstitial hyperthermia, is in the early stages of investigation. In accordance with the procedure used in a current national trial protocol, a 60-minute hyperthermia treatment is administered after catheters are placed into the tumor area while the patient is under general anesthesia. This is immediately followed by loading of radioactive Iridium-192 seeds into the catheters for a defined period of time. Once the prescribed radiation dose is delivered, the radioactive sources are removed and a second, 60-minute hyperthermia treatment is administered. Clinical trials with hyperthermia in combination with radiation have increased in recent years. Nurses caring for these patients need to become more knowledgeable about this investigational therapy. This paper provides an overview of the biologic rationale for this therapy, as well as a description of the delivery method and clinical application. Specific related nursing interventions are defined in a nursing protocol.
Brandt
B B
BB
Harney
J
J
D001918:Brachytherapy / Q000379:methods*; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods* / Q000451:nursing; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D010347:Patient Care Planning
D007496:Iridium Radioisotopes